US2002164674A1PendingUtilityA1

Tandem fluorescent protein constructs

Assignee: UNIV CALIFORNIAPriority: Jan 31, 1996Filed: Jan 25, 2002Published: Nov 7, 2002
Est. expiryJan 31, 2016(expired)· nominal 20-yr term from priority
C07K 2319/00C12Q 1/37G01N 33/542G01N 2333/43595C07K 14/43595C12Q 1/485
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides tandem fluorescent protein construct including a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a linker moiety that couples the donor and acceptor moieties. The donor and acceptor moieties exhibit fluorescence resonance energy transfer which is eliminated upon cleavage. The constructs are useful in enzymatic assays.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A tandem fluorescent protein construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a linker moiety that couples the donor and acceptor moieties, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited.  
     
     
         2 . The construct of  claim 1  wherein the donor moiety and acceptor moiety are Aequorea-related fluorescent protein moieties.  
     
     
         3 . The construct of  claim 2  wherein the donor moiety is P4-3 or W7 and the acceptor moiety is S65C or S65T.  
     
     
         4 . The construct of  claim 1  wherein the linker moiety comprises a cleavage recognition site for an enzyme.  
     
     
         5 . The construct of  claim 4  wherein the linker moiety is a peptide moiety.  
     
     
         6 . The construct of  claim 5  comprising a fusion protein including the donor moiety, the peptide moiety and the acceptor moiety in a single polypeptide.  
     
     
         7 . The construct of  claim 6  wherein the linker moiety comprises between about 5 amino acids and about 50 amino acids.  
     
     
         8 . The construct of  claim 7  wherein the linker moiety comprises between about 10 amino acids and about 30 amino acids.  
     
     
         9 . The construct of  claim 8  wherein the donor moiety is P4-3 or W7 and the acceptor moiety is S65C or S65T.  
     
     
         10 . The construct of  claim 7  comprising a cleavage recognition site for trypsin, enterokinase, HIV-1 protease, prohormone convertase, interleukin-1b-converting enzyme, adenovirus endopeptidase, cytomegalovirus assemblin, leishmanolysin, b-Secretase for APP, thrombin, renin, angiotensin-converting enzyme, cathepsin D or a kininogenase.  
     
     
         11 . The construct of  claim 6  wherein the donor moiety is positioned at the amino terminus of the polypeptide relative to the acceptor moiety.  
     
     
         12 . The construct of  claim 7  wherein the linker moiety comprises a cleavage site having a randomized amino acid sequence.  
     
     
         13 . The construct of  claim 1  wherein the linker moiety has a length between about 1 nm and about 10 nm.  
     
     
         14 . The construct of  claim 4  comprising a cleavage recognition site for b-lactamase.  
     
     
         15 . The construct of  claim 1  wherein the linker moiety comprises a cross-linker moiety.  
     
     
         16 . A recombinant nucleic acid coding for expression of a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety in a single polypeptide, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited.  
     
     
         17 . The recombinant nucleic acid of  claim 16  wherein the peptide linker moiety comprises a cleavage recognition site for a protease.  
     
     
         18 . The recombinant nucleic acid of  claim 17  wherein the donor moiety is selected from the group comprising W1B, Topaz, P4-3 and W7 and the acceptor moiety is selected from the group comprising Topaz, Emerald, S65C and S65T.  
     
     
         19 . An expression vector comprising expression control sequences operatively linked to a sequence coding for the expression of a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety in a single peptide, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited.  
     
     
         20 . An expression vector of  claim 19  adapted for function in a prokaryotic cell.  
     
     
         21 . An expression vector of  claim 19  adapted for function in a eukaryotic cell.  
     
     
         22 . A host cell transfected with an expression vector comprising an expression control sequence operatively linked to a sequence coding for the expression of a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety in a single polypeptide, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited.  
     
     
         23 . The cell of  claim 22  further comprising a protease that is not normally expressed by said cell.  
     
     
         24 . The cell of  claim 22  that is  E. coli.    
     
     
         25 . The cell of  claim 22  that is a eukaryotic cell.  
     
     
         26 . The cell of  claim 22  that is a cultured mammalian cell.  
     
     
         27 . A method for determining whether a sample contains an enzyme comprising: 
 contacting the sample with a tandem fluorescent protein construct which comprises a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a linker moiety that couples the donor and acceptor moieties and that comprises a cleavage recognition site specific for the enzyme, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    exciting the donor moiety; and    determining the degree of fluorescence resonance energy transfer in the sample, whereby a degree of fluorescence resonance energy transfer that is lower than an expected amount indicates the presence of an enzyme.    
     
     
         28 . The method of  claim 27  for determining the amount of an enzyme in a sample wherein determining the degree of fluorescence resonance energy transfer in the sample comprises determining the degree at a first and second time after contacting the sample with a tandem fluorescent protein construct, and determining the difference in the degree of fluorescence resonance energy transfer, whereby the difference in the degree of fluorescence resonance energy transfer reflects the amount of enzyme in the sample.  
     
     
         29 . The method of  claim 27  wherein the step of determining the degree of fluorescence resonance energy transfer in the sample comprises determining the amount of fluorescence from the donor moiety.  
     
     
         30 . The method of  claim 27  wherein the step of determining the degree of fluorescence resonance energy transfer in the sample comprises determining the amount of fluorescence from the acceptor donor moiety.  
     
     
         31 . The method of  claim 27  wherein the step of determining the degree of fluorescence resonance energy transfer in the sample comprises determining the ratio of the amount of fluorescence from the donor moiety and the amount of fluorescence from the acceptor moiety.  
     
     
         32 . The method of  claim 27  wherein the step of determining the degree of fluorescence resonance energy transfer in the sample comprises determining the excitation state lifetime of the donor moiety.  
     
     
         33 . The method of  claim 27  wherein the enzyme is a protease and the linker moiety is a peptide moiety having the cleavage recognition site.  
     
     
         34 . The method of  claim 33  wherein the donor fluorescent protein moiety is an Aequorea-related fluorescent protein.  
     
     
         35 . The method of  claim 34  wherein the donor moiety is P4-3 or W7 and the acceptor moiety is S6SC or S65T.  
     
     
         36 . A method of determining the amount of activity of an enzyme in a cell comprising the steps of: 
 providing a cell that expresses a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety, wherein the peptide linker moiety comprises a cleavage recognition amino acid sequence specific for the enzyme, and wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    exciting the donor moiety; and    determining the degree of fluorescence resonance energy transfer in the cell, whereby the degree of fluorescence resonance energy transfer relates the amount of enzyme activity in the cell.    
     
     
         37 . The method of  claim 36  wherein the cell is transfected with an expression vector comprising expression control sequences operably linked to a nucleic acid sequence coding for the expression of the enzyme.  
     
     
         38 . The method of  claim 37  wherein the donor fluorescent protein moiety is an Aequorea-related fluorescent protein.  
     
     
         39 . The method of  claim 38  wherein the donor moiety is P4-3 or W7 and the acceptor moiety is S65C or S65T.  
     
     
         40 . The method of  claim 36  wherein the step of providing a cell comprises inducing expression of the construct to produce a sudden increase in the expression of the construct, and the step of determining the degree of fluorescence resonance energy transfer comprises determining the degree at a first and a second time after expression of the construct and determining the difference between the first and second time, whereby the difference reflects the amount of enzyme.  
     
     
         41 . A method of determining the amount of activity of an enzyme in a sample from an organism comprising the steps of: 
 providing a sample from an organism having a cell that expresses a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety, wherein the peptide linker moiety comprises a cleavage recognition amino acid sequence specific for the enzyme, and wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    exciting the donor moiety; and    determining the degree of fluorescence resonance energy transfer in the sample, whereby the degree of fluorescence resonance energy transfer reflects the amount of enzyme activity in the cell.    
     
     
         42 . A method for determining whether a compound alters the activity of an enzyme comprising the steps of: 
 contacting a sample containing a known amount of the enzyme with the compound and with a tandem fluorescent protein construct which comprises a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a linker moiety that couples the donor and acceptor moieties and that comprises a cleavage recognition site specific for the enzyme, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    exciting the donor moiety; and    determining the amount of enzyme activity in the sample as a function of the degree of fluorescence resonance energy transfer in the sample.    
     
     
         43 . The method of  claim 42  wherein the enzyme is a protease and the compound is at a predetermined concentration of at least 1 μM.  
     
     
         44 . The method of  claim 42  further comprising the step of comparing the amount of activity in the sample with a standard activity for the same amount of the enzyme, whereby a difference between the amount of enzyme activity in the sample and the standard activity indicates that the compound alters the activity of the enzyme.  
     
     
         45 . A method for determining whether a compound alters the activity of an enzyme in a cell comprising the steps of: 
 providing first and second cells that express a tandem fluorescent protein construct, the construct comprising a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a peptide linker moiety, wherein the peptide linker moiety comprises a cleavage recognition amino acid sequence specific for the enzyme, and wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    contacting the first cell with an amount of the compound;    contacting the second cell with a different amount of the compound;    exciting the donor moiety in the first and second cell;    determining the degree of fluorescence resonance energy transfer in the first and second cells; and    comparing the degree of fluorescence resonance energy transfer in the first and second cells, whereby a difference in the degree of fluorescence resonance energy transfer indicates that the compound alters the activity of the enzyme.    
     
     
         46 . A tandem fluorescent protein construct comprising a donor moiety, an acceptor moiety and a linker moiety that couples a donor and acceptor moiety, wherein one of the donor or acceptor moieties is a fluorescent protein and one is a non-protein compound fluorescent moiety, and wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited.  
     
     
         47 . The construct of  claim 46  wherein the fluorescent protein moiety is an Aequorea-related florescent protein moiety.  
     
     
         48 . A method of testing for cleavage enzyme activity comprising: 
 contacting a cleavage enzyme with a tandem fluorescent protein construct which comprises a donor fluorescent protein moiety, an acceptor fluorescent protein moiety and a linker moiety that couples the donor and acceptor moieties and that comprises at least one cleavage recognition site, wherein the donor and acceptor moieties exhibit fluorescence resonance energy transfer when the donor moiety is excited;    exciting the donor moiety; and 
 determining the presence of fluorescence resonance energy transfer between the donor and the acceptor moieties,  
   wherein a decrease in fluorescence resonance energy transfer indicates the presence of a cleavage recognition site that is cleaved by the cleavage enzyme.    
     
     
         49 . The method of  claim 48  wherein the cleavage enzyme is a protease.  
     
     
         50 . The method of  claim 49  wherein the cleavage enzyme is an orphan protease.  
     
     
         51 . The method of  claim 50  wherein the cleavage recognition site has a random amino acid sequence.  
     
     
         52 . The method of  claim 51  wherein the cleavage enzyme is contacted with the tandem fluorescent protein construct by expressing the cleavage enzyme and the tandem fluorescent-protein construct in a cell.  
     
     
         52 . The method of  claim 51  wherein the cleavage enzyme is expressed using an inducable promoter and optionally exposing the cell to an inducer of the inducable promoter for less than two hours, wherein the cleavage enzyme is transiently expressed.  
     
     
         53 . The method of  claim 52  wherein the cleavage enzyme and the tandem fluorescent protein construct have a signal sequence directing expression of protein into a vesicle.  
     
     
         54 . The method of  claim 51  wherein the cell is part of a library of individual clones, wherein different said clones have been transfected with tandem fluorescent protein constructs having different cleavage recognition sites.  
     
     
         55 . The method of  claim 54  further comprising selecting clones from said library that have cleavage recognition sites cleaved by proteases.  
     
     
         56 . The method of  claim 55  wherein the selecting of the clones comprises identifying the clones with a Fluorescent Activated Cell Sorter (FACS) or luminescent assay based sorter.

Join the waitlist — get patent alerts

Track US2002164674A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.